team consisting of: Aynaz Kianmehr, Voitech Hradil, Kevin Ullmann, Mark Jaboreck, David Puertollano Martin and Nils Kriedemann successfully participated in this year's marathon in Hannover. The team made

0511-532-9121 Viemann.Dorothee @ mh-hannover.de Go to profile PD Dr. med. Martin Wetzke Oberarzt 0511-532-3204 Wetzke.Martin @ mh-hannover.de Go to profile

politicians also visited the Cluster of Excellence REBIRTH. In the LEBAO, represented by Prof. Ulrich Martin and Dr. Ina Gruh, human stem cell derived cardiac muscle cells were presented.

consortium has been awarded a grant of more than 3 million Euro and is coordinated by Prof. Dr. Ulrich Martin. The aim of the joint project is to prepare the first worldwide clinical application of iPSC-based

Jan Hegermann, Christoph Wredej, Christian Mühlfeld, Boris Chichkov, Martin Fischer, Thomas Thum, Antonio Francino, Ulrich Martin, Joachim Meißner, Robert Zweigerdt, Theresia Kraft, Journal of Molecular [...] Wunderlich S, Merkert S, Weber N , Osten F , de la Roche J, Polten F, Wollert K, Kraft T , Fischer M Martin U, Gruh I, Kempf H, Zweigerdt R. Stem Cell Reports. 2019 Aug 13; 13(2):366-379. doi: 10.1016/j.stemcr

clinic Sabine Iseni University outpatient clinic Sarah Kupfer University outpatient clinic Yolanda Martin Franco di Michele University outpatient clinic Anna Minor University outpatient clinic Andrea Richter

Burn Center Copyright: Martin Bargiel We provide state-of-the-art surgical care for patients who have sustained burn injuries. We work closely with the Department of Anesthesia & Critical Care to treat

2018 Teilprojekt 1 (MHH: Cebotari, Martin; DPZ, ITEM): hiPS-Zell-basierte Therapie des Myokardinfarktes im nicht-humanen Primatenmodell Teilprojekt 2 (MHH: Köhl, Martin; Miltenyi): GMP-konforme Reprogrammierung [...] ethischer und rechtlicher Fragen Teilprojekt C (MHH: Martin, Haverich): Koordination des iCARE-Verbundes Subprojects Subproject 1 (MHH: Cebotari, Martin; DPZ, ITEM): Transplantation of genetically enriched [...] Innovative Stem Cell Technologies in Personalized Medicine ”, a team was assembled headed by Prof. Ulrich Martin. This team hypothesized that the therapeutic application of iPSC-derived cardiomyocytes (CMs) is

REBIRTH as well as the individual student cohorts. The chairman of the committee is Professor Ulrich Martin, the vice-chairwoman is Professor Ina Gruh.